Poland· PL-100527718
Tryngolza
A medicinal product containing olezarsen, registered in Poland by Swedish Orphan Biovitrum AB.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Olezarsen
- Manufacturer
- Swedish Orphan Biovitrum AB
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin07350031445633
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olezarsen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTRYNGOLZA 80 MG SOLUCION INYECTABLE EN PLUMA PRECARGADASwedish Orphan Biovitrum Ab (Publ)
- SwedenTryngolza 80 mg Injektionsvätska, lösning i förfylld injektionspennaSwedish Orphan Biovitrum International AB
- NetherlandsTryngolza 80 mg oplossing voor injectie in een voorgevulde penSwedish Orphan Biovitrum AB (publ)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tryngolza
- Liechtenstein · Tryngolza
- Norway · Tryngolza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19ce0b15-1f2d-4289-9748-6bd4be352e2a GET /v1/drugs/19ce0b15-1f2d-4289-9748-6bd4be352e2a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "80 mg",
"packaging": "Rp ¦ EU/1/25/1969/001 ¦ 164467\n1 wstrzyk. 0,8 ml\n¦ UR/Z/4b/249/26 - 07350031445633",
"substance": "Olezarsen 80 mg",
"common_name": "Olezarsen",
"pl_product_id": "100527718",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about olezarsen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.